Back

Rare disease genome editing market seen reaching $12.60 billion by 2035

Verifying
  • SNS Insider projects the rare disease genome editing market will reach USD 12.60 billion by 2035.
  • USD 4.34 billion was the market value recorded for 2025.
  • North America held the largest regional share at approximately 42.86% in 2025.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.